Related Experiment Videos
Immunosuppression and infection in multiple myeloma
Seminars in Oncology
|September 1, 1986
Summary
Patients with multiple myeloma face a higher risk of severe bacterial infections due to immune system deficits. Further research is needed on treatments like Pneumovax and IV gamma globulin for these patients.
Area of Science:
- Immunology
- Hematology
- Infectious Diseases
Background:
- Multiple myeloma patients exhibit increased susceptibility to severe bacterial infections.
- Key immune deficits include impaired antibody response, complement dysfunction, and granulocyte defects.
- Suppressor monocytes are implicated in the depressed humoral immune response observed in these patients.
Purpose of the Study:
- To summarize the immune system deficits in multiple myeloma patients.
- To discuss potential prophylactic and therapeutic strategies against bacterial infections.
Main Methods:
- Review of existing literature on immune function in multiple myeloma.
- Analysis of the impact of immune deficits on infection risk.
- Evaluation of current and potential treatment options.
Main Results:
- Multiple myeloma is associated with significant immune deficiencies, increasing infection risk.
- The role of suppressor monocytes in humoral response depression is highlighted.
- Pneumovax is recommended, but its efficacy in myeloma patients requires validation.
Conclusions:
- Patients with multiple myeloma require careful management of infection risks.
- Further studies are essential to confirm the effectiveness of Pneumovax and explore other interventions like IV gamma globulin.